发明名称 COMBINATION DRUGS
摘要 Drugs useful as preventives and remedies for urinary frequency, urinary incontinence, asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, arthritis deformans, pain, cough, irritable bowel syndrome, vomiting, depression, anxiety, manic-depression or schizophrenia which comprise a combination of an NK-1 receptor antagonist and an NK-2 receptor antagonist and/or a cholinolytic. More specifically, drugs comprising a combination of a compound represented by the following formula (I) [wherein the ring M represents a heterocycle having, as the partial structure -X-Y< thereof, -N=C<, -CO-N< or -CS-N<; R<a> and R<b> are bonded to each other to form the ring A, or R<a> and R<b> may be the same or different and each represents hydrogen or a substituent in the ring M; the rings A and B are each an optionally substituted homocycle or heterocycle and at least one of them is an optionally substituted heterocycle; the ring C is an optionally substituted homocycle or heterocycle; the ring Z is an optionally substituted nitrogen-containing heterocycle; and n is an integer of 1 to 6], its salt or a prodrug thereof with an NK-2 receptor antagonist and/or a cholinolytic: (I)
申请公布号 WO02051440(A1) 申请公布日期 2002.07.04
申请号 WO2001JP11231 申请日期 2001.12.21
申请人 TAKEDA CHEMICAL INDUSTRIES, LTD.;DOI, TAKAYUKI;HASHIMOTO, TADATOSHI;KAMO, IZUMI 发明人 DOI, TAKAYUKI;HASHIMOTO, TADATOSHI;KAMO, IZUMI
分类号 A61K31/221;A61K31/4468;A61K31/551;A61K45/06;A61P1/00;A61P1/08;A61P11/00;A61P11/14;A61P19/02;A61P25/18;A61P25/22;A61P25/24;A61P29/00;A61P43/00;(IPC1-7):A61K45/06;A61K31/446 主分类号 A61K31/221
代理机构 代理人
主权项
地址